Long-Term Efficacy and Safety of Rifaximin in Japanese Patients with Hepatic Encephalopathy: A Multicenter Retrospective Study.
Hideto KawarataniYasuteru KondoRyoji TatsumiNaoto KawabeNorikazu TanabeAkira SakamakiKazuo OkumotoYoshihito UchidaKei EndoTakumi KawaguchiTsunekazu OikawaYoji IshizuShuhei HigeTaro TakamiShuji TeraiYoshiyuki UenoSatoshi MochidaYasuhiro TakikawaTakuji TorimuraTomokazu MatsuuraMasatoshi IshigamiKazuhiko KoikeHitoshi YoshijiPublished in: Journal of clinical medicine (2022)
The long-term rifaximin treatment was effective and safe for patients with HE, including Child-Pugh C.